oral semaglutide vs trulicity Dosing Patterns of Dulaglutide and in Patients with Type 2 Diabetes in the United Kingdom and Germany: A Retrospective Cohort Study | Advances in Therapy Once-weekly Trulicity® (dulaglutide) demonstrates significantly
Description
Event-free survival was estimated using KaplanMeier methods, and between-group differences were assessed using the log-rank test
The included studies were published between 2024 and 2025, and primarily conducted in the USA ( n = 7), with one study from Spain
Initial weight loss may be gradual as the body adapts to the medication
What to expect: Mild nausea is common but typically manageable
In summary, pioglitazone and vitamin E are now recommended as pharmacotherapies for biopsy-proven NASH patients with and without diabetes, respectively, although long-term efficacy or safety should be established (Table 1) [5,6,7,8]
Just a different manufacturer and a lower price tag
